Q1 2025 Walgreens Boots Alliance Inc Earnings Call Transcript
Key Points
- Walgreens Boots Alliance Inc (WBA) reported better-than-expected first-quarter results with a 6.9% increase in sales on a constant currency basis.
- The company maintained script market share in the US pharmacy segment and saw strong returns from its international business.
- Walgreens Boots Alliance Inc (WBA) is executing a Footprint Optimization Program, which has shown early positive results, including better-than-expected script retention and employee engagement.
- The company has successfully renegotiated contracts with PBMs to better align reimbursement with costs, particularly for high-cost drugs.
- Walgreens Boots Alliance Inc (WBA) improved free cash flow this quarter through decreased capital expenditures and higher adjusted operating income, excluding non-cash impacts.
- Adjusted EPS declined by 23% year over year, driven by prior year sale-leaseback gains and lower Cencora equity income.
- The US retail segment faced challenges with a 4.6% decline in comparable retail sales, impacted by lower consumer discretionary spending and a weaker cough, cold, and flu season.
- The company is facing ongoing pressure from accumulated inflation and higher interest rates affecting consumer behavior.
- Walgreens Boots Alliance Inc (WBA) is still in the early stages of its turnaround strategy, indicating that substantial work remains to be done.
- The company is undergoing a sale process for noncore assets like VillageMD, with the intent to exit and redeploy proceeds to reduce net debt, highlighting ongoing restructuring challenges.
Good day. And thank you for standing by. Welcome to Walgreens Boots Alliance first-quarter results conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Eric Wasserstrom, Senior Vice President of Investor Relations. Please go ahead.
Good morning and thank you for joining us for the Walgreens Boots Alliance earnings call for the first quarter of fiscal year 2025. I'm Eric Wasserstrom, Senior Vice President of Investor Relations. Joining me on today's call are Tim Wentworth, our Chief Executive Officer; and Manmohan Mahajan, Global Chief Financial Officer.
In addition, Mary Langowski, Executive Vice President and President of Walgreens Health; Rick Gates, Senior Vice President and Walgreen's Chief Pharmacy Officer; and Tracey Brown, President of Walgreens Retail and Chief Customer Officer, will participate in Q&A.
As always,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
